Related Experiment Video

Updated: Aug 22, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
06:07

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for

Maria Manczak1, Byung S Park, Youngsin Jung

  • 1Neurogenetics Laboratory, Neurological Sciences Institute, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR, USA.

Neuromolecular Medicine
|April 13, 2004
PubMed

Insights

Mitochondrial dysfunction is key in Alzheimer's disease (AD). This study found complex I gene downregulation and complex III/IV gene upregulation in AD brains, suggesting altered energy demands and potential compensation mechanisms.

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Genetics

Background:

  • Mitochondrial dysfunction is increasingly implicated in Alzheimer's disease (AD) pathogenesis.
  • Defects in oxidative phosphorylation (OXPHOS) are a key aspect of this mitochondrial dysfunction.
  • Understanding the role of mitochondrial gene expression in AD is crucial for unraveling disease mechanisms.

Purpose of the Study:

  • To investigate the mRNA expression of mitochondrial genes involved in OXPHOS in brain specimens from early and definite Alzheimer's disease (AD) patients.
  • To identify specific mitochondrial genes and complexes that are differentially expressed in the brains of AD patients compared to controls.
  • To explore the relationship between mitochondrial gene expression patterns and potential compensatory mechanisms or oxidative damage in AD.

Main Methods:

  • Quantitative reverse transcription (RT)-PCR was used to analyze the mRNA expression of 11 mitochondrial-encoded OXPHOS genes in brain samples from early AD, definite AD, and control groups.
  • Immunofluorescence techniques were employed to determine the differential expression of specific mitochondrial genes (NADH 15-kDa subunit, cytochrome oxidase subunit 1, ATPase delta-subunit) in brain sections.
  • Double-labeling immunofluorescence was used to investigate the co-localization of oxidative damage markers (8-hydroxyguanosine) with specific mitochondrial proteins (cytochrome oxidase) in AD brains.

Main Results:

  • A significant downregulation of mitochondrial genes in Complex I of OXPHOS was observed in both early and definite AD brain specimens, with subunit 1 showing the most pronounced decrease.
  • Conversely, mRNA expression of genes in Complexes III and IV of OXPHOS was increased in AD brains, suggesting heightened energy demands.
  • Immunofluorescence revealed differential expression of cytochrome oxidase and ATPase delta-subunit in specific neuronal subpopulations in AD brains, with evidence of oxidative damage in a subset of cytochrome oxidase-overexpressing neurons.

Conclusions:

  • The study demonstrates altered mitochondrial gene expression in Alzheimer's disease, characterized by Complex I downregulation and Complex III/IV upregulation, indicating dysregulated energy metabolism.
  • Variations in mitochondrial gene expression across AD patients suggest that mitochondrial DNA defects may contribute to the phenotypic heterogeneity observed in AD.
  • Increased cytochrome oxidase expression may represent a compensatory response by surviving neurons or an early sign of mitochondrial alteration linked to oxidative damage in AD brains.

More Related Videos

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Cholinergic Ligand–dependent Modulation of Oxidative Phosphorylation Coupling in Digitonin-permeabilized BE(2)-C Neuroblastoma Cells14:39

Cholinergic Ligand–dependent Modulation of Oxidative Phosphorylation Coupling in Digitonin-permeabilized BE(2)-C Neuroblastoma Cells

Published on: April 28, 2026

Related Concept Videos

Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...